Definium Therapeutics, Inc. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
Definium Therapeutics, Inc. (DFTX) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of -$407.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2024-02-28
- Definium Therapeutics, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-12-31 was $0.00.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-09-30 was $0.00.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-06-30 was $0.00.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2022-03-31 was -$407.00K.
- Definium Therapeutics, Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2022 was -$407.00K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | -$407.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | -$407.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$407.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$407.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |